Shift Bioscience is revealing new therapeutic opportunities at the intersection of aging and disease. Guided by an AI-powered target discovery engine, Shift is advancing its first program, SB101, for late-stage MASH, with a broader mandate to address age-related diseases and enable longevity.
| Website | https://shiftbioscience.com |
| Revenue | $3 million |
| Employees | 22 (13 on RocketReach) |
| Founded | 2017 |
| Technologies |
JavaScript
,
HTML
,
Microsoft Outlook
+8 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Business Services |
| Keywords | Life Extension, Cellular Reprogramming, Aging Reversal, Molecular Biology, High Throughput, Cellular Therapy, Regenerative Medicine, Anti Aging, Longevity Research, Biotechnology, Drug Discovery, Bioscience, Clinical Research, In Vitro |
| Competitors | UNITY Biotechnology, Calico Life Sciences, Synthego Corporation, Insilico Medicine, Elysium Health, Geroscience, Life Biosciences, Rejuveron Telomere Therapeutics, LyGenesis +25 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies |
Looking for a particular Shift Bioscience employee's phone or email?
The Shift Bioscience annual revenue was $3 million in 2026.
Andrew Armour is the CFO of Shift Bioscience.
13 people are employed at Shift Bioscience.
The NAICS codes for Shift Bioscience are [54171, 541, 541714, 5417, 54].
The SIC codes for Shift Bioscience are [873, 87].